Within triple negative breast cancer (TNBC), nuclear expression of YAP/TAZ is strongly associated with and showed poorer clinical outcomes for disease-free survival (DFS) and OS (63–65). This evidence concerns the gene YAP1 and triple-negative breast carcinoma.